Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination.

Source:http://linkedlifedata.com/resource/pubmed/id/2563003

Lancet 1989 Jan 7 1 8628 15-8

Download in:

View as

General Info

PMID
2563003